Faculty of Medicine, University of Helsinki, Helsinki, Finland
Faculty of Science and Engineering, University of Turku, Turku, Finland.
BMJ Open. 2022 May 9;12(5):e053693. doi: 10.1136/bmjopen-2021-053693.
This study explored self-reported knowledge and interest to learn more about medicines research, development and health technology assessment among Finnish general public. It also aimed to define possible knowledge gaps and needs for public education regarding these topics.
Online survey with 503 participants. The questionnaire was originally developed as a part of the Needs Assessment Work Package of the European Patients' Academy on Therapeutic Innovation Project. The survey was carried out in Finland in 2019.
The survey was conducted as an online survey by Kantar TNS Gallup Forum online panel. The data were analysed by using the freely available programming language R. Relationships between the demographic characteristics (such as age, gender and education level) of respondents and their knowledge or interest in medicines research and development were determined using Pearson's χ tests. Statistically significant responses of demographic characteristics in the respondents' knowledge or interest in medicines research were determined by logistic regression.
Of the 503 respondents (age 16-64) only 12% reported having good or very good knowledge of medicines research and development in general. Regarding health technology assessment, pharmacoeconomics and regulation, the percentage of respondents reporting good or very good knowledge was as low as 8%. Respondents were most interested in learning more about predictive and personalised medicine (47%) and least interested in medicines regulation (30%) and pharmacoeconomics (31%).
Self-reported knowledge about medicines research and development and health technology assessment appears to be very low in Finland. Patient and public participation is recognised as an important and essential element in up-to-date medical research and assessment of new treatments. In order to participate as an active and equal partner in these processes, the public needs more information and education in these topics.
本研究旨在探讨芬兰普通公众对药品研究、开发和卫生技术评估的自我报告知识和学习兴趣。它还旨在确定这些主题的公众教育可能存在的知识差距和需求。
503 名参与者的在线调查。该问卷最初是作为欧洲患者治疗创新项目治疗创新学院需求评估工作包的一部分开发的。该调查于 2019 年在芬兰进行。
该调查通过 Kantar TNS Gallup Forum 在线小组作为在线调查进行。使用免费提供的编程语言 R 分析数据。使用 Pearson's χ 检验确定受访者的人口统计学特征(如年龄、性别和教育水平)与其对药品研究和开发的知识或兴趣之间的关系。通过逻辑回归确定受访者对药品研究的知识或兴趣的人口统计学特征的统计学显著响应。
在 503 名(16-64 岁)受访者中,只有 12%的人报告对药品研究和开发有良好或非常好的了解。在卫生技术评估、药物经济学和法规方面,报告有良好或非常好知识的受访者比例低至 8%。受访者最感兴趣的是了解更多关于预测性和个体化医学(47%),而对药品监管(30%)和药物经济学(31%)最不感兴趣。
自我报告的药品研究和开发以及卫生技术评估知识在芬兰似乎非常低。患者和公众参与被认为是最新医学研究和评估新治疗方法的重要和必要组成部分。为了在这些过程中作为积极和平等的参与者参与,公众需要在这些主题上获得更多的信息和教育。